Neural Targeting Repair Therapy

With the continuous development and advancement of modern medical technology, there have been numerous changes in the treatment of many diseases, especially in the treatment of neurological diseases. Neural targeting repair therapy is a novel treatment technique that treats the nervous system of patients by selecting appropriate targets in the waist or neck of the patient without damaging healthy nerves.

1. What is Neural Targeting Repair Therapy?

Neural targeting repair therapy is the latest neural repair technique in China. This therapy directly acts on the injured part of the patient's nervous system through intravenous or arterial intervention by selecting corresponding treatment targets in the waist or neck of the patient without damaging the normal nerves of the patient, thus achieving the purpose of neural repair. This is currently the latest technology in China.

2. Scope of Neural Targeting Repair Therapy

Neural targeting repair therapy can be used to treat a wide range of neurological diseases, including:

• Cerebrovascular diseases: sequelae of cerebrovascular diseases such as transient ischemic attack, cerebral infarction, lacunar infarction, cerebral thrombosis, cerebral hemorrhage, subarachnoid hemorrhage, and cerebral trauma, resulting in hemiplegia and paraplegia.
• Neurodegenerative diseases: motor neuron diseases, progressive muscular atrophy, progressive bulbar palsy, primary lateral sclerosis, brain atrophy, Alzheimer's disease, and cerebellar ataxia caused by multisystem atrophy.
• Movement disorders: Parkinson's disease, chorea minor, dystonia and torsion, Huntington's disease, essential tremor, poliomyelitis, tic disorder, torsion dystonia, and other motor diseases.
• Spinal cord diseases: sequelae of acute myelitis, spinal cord compression, spinal cord injury, syringomyelia, and progressive bulbar palsy.
• Neuromuscular junction and muscle diseases: polymyositis and progressive muscular dystrophy.
• Inherited neurological diseases: inherited ataxia and inherited spastic paraplegia.
• Developmental abnormalities of the nervous system: cerebral palsy, attention deficit hyperactivity disorder (autism, autism spectrum disorder), mental retardation (developmental delay, intellectual disability, underdevelopment, mental deficiency, mental retardation, intellectual disability).
• Desmyelinating diseases of the nervous system: multiple sclerosis, leukodystrophy, and Guillain-Barre syndrome.

This therapy offers a promising approach for the treatment of a diverse range of neurological diseases, providing patients with new hope for recovery and improved quality of life.